Amgen's Chief Technology Officer Dr David Reese to retire.

{
  "signal_id": "03affc77-8a39-4619-b5d8-b3612c20ef6e",
  "signal_type": "news",
  "signal_subtype": "hires",
  "detected_at": "2026-04-24T00:00:00+00:00",
  "company": {
    "name": "Amgen",
    "domain": "amgen.com"
  },
  "data": {
    "url": "https://www.europeanpharmaceuticalreview.com/amgens-chief-technology-officer-dr-david-reese-to-retire/2135288.article",
    "title": "Amgen's Chief Technology Officer Dr David Reese to retire.",
    "contact": "Sean Bruich",
    "excerpt": "Amgen's Chief Technology Officer Dr David Reese to retire.\n\nHis two-decade tenure at the biopharmaceutical company has strengthened its aim for \"convergent innovation\" in medicine development.\n\nAmgen's 21-year veteran, Dr David Reese, is retiring as its Executive Vice President and Chief Technology Officer on 30 June.\n\nTo support this change, from 1 June, Dr James Bradner will serve as Executive Vice President, Research and Development, Artificial Intelligence and Data. Additionally, Sean Bruich will become Amgen's Senior Vice President, Chief Technology Officer. At present, he is the firm's SVP, Artificial Intelligence (AI) & Data.\n\nAmgen intends that the restructure will improve convergence of biology, data science, and advanced technologies to accelerate its own medicine development.\n\nIn his most recent post as Chief Technology Officer, Dr Reese encouraged the early adoption of technology and AI, particularly in R&D, Amgen noted.\n\nThe company's Chairman and Chief Executive Officer, Robert Bradway, said: \"Dave recognised early the impact that advances in biology and technology would have on our industry and helped lead Amgen through that shift. The capabilities he built position us to advance what we call convergent innovation and strengthen our ability to serve patients in the years ahead.\"\n\nHaving joined the firm in 2005, Dr Reese initially led Amgen's clinical development...",
    "summary": "Amgen Foundation, Inc. hires Sean Bruich as Senior Vice President, Chief Technology Officer.",
    "category": "hires",
    "found_at": "2026-04-24T00:00:00Z",
    "planning": false,
    "image_url": "https://d3t5t78xsxj5vn.cloudfront.net/Pictures/1024x536/6/7/9/20679_shutterstock_2695786665_766589.jpg",
    "job_title": "Senior Vice President, Chief Technology Officer",
    "confidence": 0.8858,
    "assets_tags": [
      "research_and_development"
    ],
    "product_tags": [
      "general_technology"
    ],
    "published_at": "2026-04-24T00:00:00Z",
    "job_title_tags": [
      "general_technology",
      "directors",
      "engineering"
    ],
    "article_sentence": "Additionally, Sean Bruich will become Amgen's Senior Vice President, Chief Technology Officer."
  }
}

curl https://signals.autobound.ai/v1/signals/03affc77-8a39-4619-b5d8-b3612c20ef6e \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"amgen.com","limit":20}'